A detailed history of Us Bancorp \De\ transactions in Ocugen, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 1,638 shares of OCGN stock, worth $1,179. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,638
Previous 3,526 53.55%
Holding current value
$1,179
Previous $5,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$0.98 - $1.95 $1,850 - $3,681
-1,888 Reduced 53.55%
1,638 $1,000
Q2 2024

Aug 06, 2024

BUY
$1.18 - $1.98 $4,160 - $6,981
3,526 New
3,526 $5,000
Q1 2023

May 09, 2023

BUY
$0.82 - $1.33 $233 - $379
285 Added 11.19%
2,833 $2,000
Q4 2022

Feb 13, 2023

BUY
$1.11 - $1.87 $1,014 - $1,709
914 Added 55.94%
2,548 $3,000
Q3 2022

Oct 27, 2022

SELL
$1.75 - $3.1 $2,938 - $5,204
-1,679 Reduced 50.68%
1,634 $3,000
Q2 2022

Aug 01, 2022

SELL
$1.83 - $3.45 $2,201 - $4,150
-1,203 Reduced 26.64%
3,313 $8,000
Q1 2022

May 11, 2022

BUY
$2.34 - $4.72 $3,928 - $7,924
1,679 Added 59.18%
4,516 $15,000
Q4 2021

Feb 11, 2022

BUY
$4.38 - $15.67 $7,892 - $28,237
1,802 Added 174.11%
2,837 $13,000
Q3 2021

Nov 10, 2021

BUY
$6.36 - $8.51 $6,582 - $8,807
1,035 New
1,035 $7,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $156M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.